0 items USD 0.00Search
- Did you mean
- biosimilar
Your search for "biosimilars" gave back 1152 results.
Biosimilar is a biologic medical product which is highly similar to another already approved biological medicine. The global Adalimumab, Infliximab...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
A biosimilar is a biologic medical product highly similar to another already approved biological medicine (the 'reference medicine')...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Biosimilar market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar is forecast to a...
Catalog:
LPI
January 2024
Price: USD 3,660.00
The global Biosimilar market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %...
Catalog:
GIR
January 2024
Price: USD 3,480.00
The global Interferon Alpha-2b Biosimilar market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Bevacizumab Biosimilar market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Biosimilars (also known as biologics, biological drugs, biological products) are pharmaceutical products produced through biotechnology, such as...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Aflibercept (Eylea) is a recombinant fusion protein that contains Ig-like domain 2 of VEGFR1 and Ig-like domain 3 of VEGFR2. It forms a fusion...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
A Remicade biosimilar is a biologic medication that is highly similar to Remicade, a brand-name biologic used to treat autoimmune diseases such as...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Biosimilar Insulin market size was valued at US$ 2502.4 million in 2023. With growing demand in downstream market, the Biosimilar Insulin...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Pertuzumab Biosimilars market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period...
Catalog:
GIR
December 2023
Price: USD 4,480.00
The global Infliximab and Biosimilar market size was valued at US$ million in 2023. With growing demand in downstream market, the Infliximab and...
Catalog:
LPI
February 2024
Price: USD 3,660.00
